Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Epithelial-mesenchymal transition and GALC expression of circulating tumor cells indicate metastasis and poor prognosis in non-small cell lung cancer.

Cancer biomarkers : section A of Disease markers - 1 Jan 2018

Liu De-Gang, Xue Lei, Li Jun, Yang Qiang, Peng Jiang-Zhou

Abstract excerpt

BACKGROUND: Circulating tumor cells (CTCs) is a promising biomarker for cancer prognosis and monitoring. Molecular characterizing of CTCs could provide beneficial information on the basis of CTCs counting. OBJECTIVE: To investigate the epithelial-mesenchymal transition (EMT) phenotypes and GALC mRNA expression of CTCs in non-small cell lung cancer (NSCLC) patients. METHODS: We analyzed the baseline number, EMT...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Carcinoma, Non-Small-Cell Lung

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Epithelial-Mesenchymal Transition

Share to Galactosylceramidase

Share to Lung Neoplasms

Share to Neoplasm Metastasis

Share to Neoplasm Staging

Share to Neoplastic Cells, Circulating

Source

Open in PubMed Open full text

Identifiers

PMID: 29758927
DOI: 10.3233/CBM-170995
PMCID: PMC13078463

Genes

GALC

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Epithelial-mesenchymal transition and GALC expression of circulating tumor cells indicate metastasis and poor prognosis in non-small cell lung cancer.PMID 29758927Read ↗

Epithelial-mesenchymal transition phenotypes of circulating tumor cells correlate with the clinical stages and cancer metastasis in hepatocellular carcinoma patients.Semantic proximity Read ↗

Effect of phenotypic detection of circulating tumor cells marked by epithelial-mesenchymal transformation on the prognosis of lung cancer: A protocol for systematic review and meta-analysis.Semantic proximity Read ↗

Epithelial circulating tumor cells with a heterogeneous phenotype are associated with metastasis in NSCLC.Semantic proximity Read ↗

Molecular Detection of EMT Markers in Circulating Tumor Cells from Metastatic Non-Small Cell Lung Cancer Patients: Potential Role in Clinical Practice.Semantic proximity Read ↗

CCR7-Positive Circulating Tumor Cells as a Biomarker for Predicting Lung Cancer RiskSemantic proximity Read ↗

Expression and clinical relevance of epithelial and mesenchymal markers in circulating tumor cells from colorectal cancer.Semantic proximity Read ↗

Phenotype of circulating tumor cell: face-off between epithelial and mesenchymal masks.Semantic proximity Read ↗

Effect of Napsin A and Circulating Tumor Cells with Mesenchymal Phenotype in Lung AdenocarcinomaSemantic proximity Read ↗

Biomarkers for the detection of circulating tumor cellsSemantic proximity Read ↗

Prognostic impact of circulating tumor cells detected with the microfluidic "universal CTC-chip" for primary lung cancer.Semantic proximity Read ↗

Prognostic and Therapeutic Significance of Circulating Tumor Cell Phenotype Detection Based on Epithelial-Mesenchymal Transition Markers in Early and Midstage Colorectal Cancer First-Line Chemotherapy.Semantic proximity Read ↗

Evaluation of epithelial-mesenchymal transitioned circulating tumor cells in patients with resectable gastric cancer: Relevance to therapy response.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.